Patents by Inventor Leda BASSIT

Leda BASSIT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents and nucleoside analogs for treatment of Zika virus
    Patent number: 11963972
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Zika virus. The compounds include pyrimidine and purine nucleosides and prodrugs thereof, including certain N4-hydroxycytidine nucleoside derivatives, sulfasalazine, and various entry inhibitors.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: April 23, 2024
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan D. Cox, Leda Bassit, Longhu Zhou, Christina Gavegnano
  • PYRROLE COMPOUNDS
    Publication number: 20230390242
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 22, 2023
    Publication date: December 7, 2023
    Inventors: Sandrine Vendeville, David Bernard Smith, Leonid Beigelman, Vladimir Serebryany, Raymond F. Schinazi, Franck Amblard, Leda Bassit
  • Elimination of hepatitis b virus with antiviral agents
    Patent number: 11629125
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: April 18, 2023
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • MONOMER AND MULTIMERIC ANTI-HBV AGENTS
    Publication number: 20230056135
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Application
    Filed: October 4, 2019
    Publication date: February 23, 2023
    Applicant: Emory University
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan Cox, Che Chen, Leda Bassit
  • Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus
    Publication number: 20230000893
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Zika virus. The compounds include pyrimidine and purine nucleosides and prodrugs thereof, including certain N4-hydroxycytidine nucleoside derivatives, sulfasalazine, and various entry inhibitors.
    Type: Application
    Filed: March 22, 2017
    Publication date: January 5, 2023
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan D. Cox, Leda Bassit, Longhu Zhou, Christina Gavegnano
  • PYRROLE COMPOUNDS
    Publication number: 20220071957
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Sandrine Vendeville, David Bernard Smith, Leonid Beigelman, Vladimir Serebryany, Raymond F. Schinazi, Franck Amblard, Leda Bassit
  • ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS
    Publication number: 20210114981
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Application
    Filed: August 20, 2020
    Publication date: April 22, 2021
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • PYRROLE COMPOUNDS
    Publication number: 20200323821
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 15, 2020
    Inventors: Sandrine Vendeville, David Bernard Smith, Leonid Beigelman, Vladimir Serebryany, Raymond F. Schinazi, Franck Amblard, Leda Bassit
  • Elimination of hepatitis B virus with antiviral agents
    Patent number: 10752584
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: August 25, 2020
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS
    Publication number: 20190241514
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Application
    Filed: March 9, 2017
    Publication date: August 8, 2019
    Applicant: EMORY UNIVERSITY
    Inventors: Raymond F. SCHINAZI, Sebastien BOUCLE, Franck AMBLARD, Ozkan SARI, Leda BASSIT